9.3 Pharmacy Practice Automation & Automated Dispensing Devices

Pharmacy Practice Automation & Automated Dispensing Devices

Massachusetts regulates automation inside the professional practice standards chapter. 247 CMR 9.11 deals with pharmacy practice automation (PPA) — the counting cells and robotic filling systems inside a licensed pharmacy. 247 CMR 9.12 deals with automated dispensing devices (ADDs).

[!IMPORTANT] These are 9.11 and 9.12. Study material that cites "247 CMR 13.00" for automated dispensing is wrong; 13.00 is nuclear pharmacies.

---

Automated Dispensing Devices — 247 CMR 9.12

The regulation is short and restrictive. A pharmacy may utilise an automated dispensing device for controlled substances provided that:

1. the ADD is located in a licensed health care facility;
2. dispensing is pursuant to a valid patient-specific prescription or order; and
3. utilisation is in accordance with all applicable laws and regulations.

Two consequences follow, and they are the heart of this topic:

[!CAUTION] (1) Location. A controlled substance ADD must sit in a licensed health care facility — a hospital unit, a licensed long-term care facility, a licensed clinic. A free-standing dispensing kiosk in a supermarket lobby, a workplace or a residential building is not a licensed health care facility.

(2) Patient-specific. Dispensing must be pursuant to a valid patient-specific prescription or order. This is what distinguishes a lawful ADD from a vending machine. A device that hands out a standard starter pack to whoever presents a code is not dispensing pursuant to a patient-specific order.

Do not assume a general Massachusetts telepharmacy or remote-kiosk authority. Where a question turns on whether a remote automated dispensing arrangement is permitted, the analysis runs through 247 CMR 9.12's two conditions and any specific Board approval, not through a generic telepharmacy framework.

---

Pharmacy Practice Automation — 247 CMR 9.11

A pharmacy using PPA must implement and maintain policies and procedures pertaining to the automation that include:

• operation and maintenance;
• security;
• controlled substance accountability;
• quality assurance; and
• stocking and return activities.

The lot commingling rule

This is the distinctive Massachusetts requirement and it is genuinely practical. Automated counting cells are refilled from successive manufacturer containers, so a single cell commonly holds product from more than one lot. The regulation therefore requires that:

• the lot number of the product dispensed can be identified; and
• if lot numbers are commingled in a single cell, the pharmacy maintains a policy and procedure to quarantine ALL commingled lot numbers in the event that a single lot number is recalled.

[!WARNING] The recall consequence is the point. Because the pharmacy cannot tell which tablets in a commingled cell came from the recalled lot, a recall of one lot quarantines everything in that cell. This is the operational reason many pharmacies run cells to empty before refilling, and it is the reason returning dispensed product to an automated cell is problematic.

Stocking and returns

Stocking and return activities must be covered by written policy. Before loading, the identity, strength, dosage form, lot number and expiry of the product should be confirmed against the cell assignment, and a verification step — commonly barcode confirmation of both the source container and the destination cell — should be built into the procedure. Note that this is a matter of the pharmacy's required policies and procedures under 247 CMR 9.11 rather than a prescriptive statewide barcode mandate.

Cross-contamination

Counting cells and trays must be cleaned in accordance with manufacturer specifications, and dedicated equipment should be used for highly sensitising drugs such as penicillins, cephalosporins and sulfonamides.

---

What Automation Cannot Do

Automation changes who moves the tablets. It does not change who is responsible.

In an institutional setting, an ADD ordinarily releases a medication for a specific patient only after a pharmacist has reviewed and approved the order. Where a facility permits an override for genuinely urgent situations, the override must be governed by written policy, restricted to authorised clinicians and defined medications, logged in the audit trail, and reviewed by a pharmacist. Build the review interval from the facility's approved policy rather than assuming a fixed statewide figure.

---

Security and Audit

An automated system that holds controlled substances must maintain controlled substance accountability as a matter of required policy: unique user identification, restricted access appropriate to role, a complete transaction record showing who accessed what and when, and reconciliation of discrepancies. An unresolved controlled substance discrepancy is escalated to the Manager of Record, and if it turns out to be a significant theft or loss the reporting duties in 21 CFR 1301.76(b) and 247 CMR 20.03(7) are triggered.

---

Worked Traps

• A chain proposes to install a prescription-dispensing kiosk in a supermarket lobby. Not permitted for controlled substances — 247 CMR 9.12 requires the device to be located in a licensed health care facility.
• A long-term care facility ADD is stocked with an emergency supply released to nursing staff on a general protocol rather than a patient-specific order. Fails the second condition of 247 CMR 9.12.
• A single lot of one product in a commingled counting cell is recalled and the pharmacy pulls only the containers it can identify. Non-compliant — the policy must quarantine all commingled lot numbers in that cell.
• A technician performs the final check on prescriptions produced by the robot because the machine scanned them. Violation — final dispensing process validation is the pharmacist's under 247 CMR 9.04.